INCY:NASDAQ
Incyte Corp
$120.62
arrow_downward
-0.88%(-1.07) 1D
Nov 13, 10:40:25 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$121.89
High
$122.06
Low
$119.84
Mkt. cap
24.52B
Avg. vol.
1.82M
Volume
109.25K
P/E ratio
64.14
52-wk high
$132.60
52-wk low
$89.25
EPS
$1.88
Beta
0.78
Shares outstanding
203.83M
No. of employees
3K
Open
$121.89
High
$122.06
Low
$119.84
Mkt. cap
24.52B
Avg. vol.
1.82M
Volume
109.25K
P/E ratio
64.14
52-wk high
$132.60
52-wk low
$89.25
EPS
$1.88
Beta
0.78
Shares outstanding
203.83M
No. of employees
3K
News stories
From web sources and news partners
Yahoo Finance
·
10 hours ago
How Incyte Trial And New Cancer Data Will Impact Natera Stock
News Corp
·
1 day ago
Incyte Corp. stock underperforms Wednesday when compared to competitors despite daily gains
MarketWatch
·
1 day ago
Incyte Corp. stock underperforms Wednesday when compared to competitors despite daily gains
Investing.com
·
3 days ago
Natera, Incyte partner on colorectal cancer trial using MRD test
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorHealth Care
IndustryBiotechnology
Websiteincyte.com